# Early CPAP in COVID-19 Patients With Respiratory Failure.

> **NCT04326075** · NA · COMPLETED · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 68 (actual)

## Conditions studied

- CPAP Ventilation
- COVID-19
- Emergency Departments

## Interventions

- **DEVICE:** CPAP treatment

## Key facts

- **NCT ID:** NCT04326075
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2022-12-15
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2022-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04326075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04326075, "Early CPAP in COVID-19 Patients With Respiratory Failure.". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT04326075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*